Variant angola marburg virus
AssigneeBoard of Regents, The University of Texas System
InventorsJoan B. Geisbert, Chad E. Mire, Thomas W. Geisbert, Robert W. Cross
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoard of Regents, The University of Texas System
InventorsJoan B. Geisbert, Chad E. Mire, Thomas W. Geisbert, Robert W. Cross
Estimating the term…
The present invention includes methods of making, and compositions comprising, a uniformly lethal filovirus for outbred small mammals by mutation of the viral genome through serial passages in a small mammal, the method comprising the steps of: obtaining a filovirus strain from a human subject; passing the filovirus strain one or more times by intramuscular injection of one or more filovirus infected tissues into an inbred small mammal until uniform lethality is obtained; passing the filovirus strain in one or more human cell lines; passing the filovirus strain one or more times by intraperitoneal injection of one or more filovirus infected tissues into an outbred small mammal until uniform lethality is obtained; and isolating the uniformly lethal filovirus obtained thereby.
A uniformly lethal MARV-Angola Filovirus strain adapted for virulence in a small mammal, wherein the original strain has the nucleotide/amino acid sequence of Mary Angola isolate Ang1379c having the GenBank Accession No. DQ447653, that comprises all of the following mutations:
Dependencies are inferred from the claim text.